SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-10-014622
Filing Date
2010-03-16
Accepted
2010-03-16 16:59:58
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a09-35851_110k.htm 10-K 1761543
2 EX-10.78 a09-35851_1ex10d78.htm EX-10.78 610357
3 EX-21.1 a09-35851_1ex21d1.htm EX-21.1 4403
4 EX-23.1 a09-35851_1ex23d1.htm EX-23.1 3180
5 EX-31.1 a09-35851_1ex31d1.htm EX-31.1 11523
6 EX-31.2 a09-35851_1ex31d2.htm EX-31.2 11526
7 EX-32.1 a09-35851_1ex32d1.htm EX-32.1 9339
8 GRAPHIC g358511ba07i001.jpg GRAPHIC 27237
  Complete submission text file 0001104659-10-014622.txt   2451055
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14895 | Film No.: 10686196
SIC: 2834 Pharmaceutical Preparations